Sort by:

Konstantinopoulos PA, Cai M, Lee EK, Krasner C, Campos SM, Liu JF, Horowitz NS, Shea M, Parsons HA, Wright AA, Bouberhan S, Penson RT, Yeku O, Hayes M, Sawyer H, Polak M, Castro CM, Cheng SC, Weipert CM, Matulonis UA

Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
JCO Precis Oncol. 2025;9:e2400882 - PMID: 40209137 - DOI: 10.1200/PO-24-00882

Matulonis UA, Vergote I, Moore KN, Martin LP, Castro CM, Gilbert L, Xia Y, Method M, Stec J, Birrer MJ, O'Malley DM

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRĪ±)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol. 2025;200:96-104 - PMID: 40700855 - DOI: 10.1016/j.ygyno.2025.06.016

Ssedyabane F, Niyonzima N, Ngonzi J, Najjuma JN, Namuli A, Okeny C, Nuwashaba D, Birungi A, Kajabwangu R, Randall TC, Castro CM, Lee H, Tusubira D

Diagnostic Accuracy of Serum P16ink4A and FOX-P3 Concentrations for Detection of Cervical Lesions Among Women Attending a Cervical Cancer Clinic in Western Uganda: A Case-Control Study.
Anal Cell Pathol (Amst). 2025;2025:1931921 - PMID: 40365511 - PMCID: PMC12074841 - DOI: 10.1155/ancp/1931921
3 CSV